Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Innate Pharma - Filing #2821023

Concept 2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
133 972 EUR
163 756 EUR
Current assets
173 451 EUR
237 605 EUR
Non-current liabilities
105 959 EUR
62 123 EUR
Current liabilities
45 488 EUR
121 822 EUR
Revenue
70 451 EUR
85 814 EUR
Profit (loss)
63 984 EUR
63 984 EUR
20 759 EUR
20 759 EUR
Other comprehensive income
22,000 EUR
627,000 EUR
Comprehensive income
805,000 EUR
827,000 EUR
63 962 EUR
63 984 EUR
627,000 EUR
20 759 EUR
20 132 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.